Heritability of Mitral Regurgitation: Observations From the Framingham Heart Study and Swedish Population.

Francesca N Delling, Xinjun Li, Shuo Li, Qiong Yang, Vanessa Xanthakis, Andreas Martinsson, Pontus Andell, Birgitta T Lehman, Ewa W Osypiuk, Plamen Stantchev, Bengt Zöller, Emelia J Benjamin, Kristina Sundquist, Ramachandran S Vasan, J Gustav Smith
{"title":"Heritability of Mitral Regurgitation: Observations From the Framingham Heart Study and Swedish Population.","authors":"Francesca N Delling,&nbsp;Xinjun Li,&nbsp;Shuo Li,&nbsp;Qiong Yang,&nbsp;Vanessa Xanthakis,&nbsp;Andreas Martinsson,&nbsp;Pontus Andell,&nbsp;Birgitta T Lehman,&nbsp;Ewa W Osypiuk,&nbsp;Plamen Stantchev,&nbsp;Bengt Zöller,&nbsp;Emelia J Benjamin,&nbsp;Kristina Sundquist,&nbsp;Ramachandran S Vasan,&nbsp;J Gustav Smith","doi":"10.1161/CIRCGENETICS.117.001736","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Familial aggregation has been described for primary mitral regurgitation (MR) caused by mitral valve prolapse. We hypothesized that heritability of MR exists across different MR subtypes including nonprimary MR.</p><p><strong>Methods and results: </strong>Study participants were FHS (Framingham Heart Study) Generation 3 (Gen 3) and Gen 2 cohort participants and all adult Swedish siblings born after 1932 identified in 1997 and followed through 2010. MR was defined as ≥ mild regurgitation on color Doppler in FHS and from <i>International Classification of Diseases</i> codes in Sweden. We estimated the association of sibling MR with MR in Gen 2/Gen 3/Swedish siblings. We also estimated heritability of MR in 539 FHS pedigrees (7580 individuals). Among 5132 FHS Gen 2/Gen 3 participants with sibling information, 1062 had MR. Of siblings with sibling MR, 28% (500/1797) had MR compared with 17% (562/3335) without sibling MR (multivariable-adjusted odds ratio, 1.20; 95% confidence interval [CI], 1.01-1.43; <i>P</i>=0.04). When we combined parental and sibling data in FHS pedigrees, heritability of MR was estimated at 0.15 (95% CI, 0.07-0.23), 0.12 (95% CI, 0.04-0.20) excluding mitral valve prolapse, and 0.44 (95% CI, 0.15-0.73) for ≥ moderate MR only (all <i>P</i><0.05). In Sweden, sibling MR was associated with a hazard ratio of 3.57 (95% CI, 2.21-5.76; <i>P</i><0.001) for development of MR.</p><p><strong>Conclusions: </strong>Familial clustering of MR exists in the community, supporting a genetic susceptibility common to primary and nonprimary MR. Further studies are needed to elucidate the common regulatory pathways that may lead to MR irrespective of its cause.</p>","PeriodicalId":10277,"journal":{"name":"Circulation: Cardiovascular Genetics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.117.001736","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Cardiovascular Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/CIRCGENETICS.117.001736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Background: Familial aggregation has been described for primary mitral regurgitation (MR) caused by mitral valve prolapse. We hypothesized that heritability of MR exists across different MR subtypes including nonprimary MR.

Methods and results: Study participants were FHS (Framingham Heart Study) Generation 3 (Gen 3) and Gen 2 cohort participants and all adult Swedish siblings born after 1932 identified in 1997 and followed through 2010. MR was defined as ≥ mild regurgitation on color Doppler in FHS and from International Classification of Diseases codes in Sweden. We estimated the association of sibling MR with MR in Gen 2/Gen 3/Swedish siblings. We also estimated heritability of MR in 539 FHS pedigrees (7580 individuals). Among 5132 FHS Gen 2/Gen 3 participants with sibling information, 1062 had MR. Of siblings with sibling MR, 28% (500/1797) had MR compared with 17% (562/3335) without sibling MR (multivariable-adjusted odds ratio, 1.20; 95% confidence interval [CI], 1.01-1.43; P=0.04). When we combined parental and sibling data in FHS pedigrees, heritability of MR was estimated at 0.15 (95% CI, 0.07-0.23), 0.12 (95% CI, 0.04-0.20) excluding mitral valve prolapse, and 0.44 (95% CI, 0.15-0.73) for ≥ moderate MR only (all P<0.05). In Sweden, sibling MR was associated with a hazard ratio of 3.57 (95% CI, 2.21-5.76; P<0.001) for development of MR.

Conclusions: Familial clustering of MR exists in the community, supporting a genetic susceptibility common to primary and nonprimary MR. Further studies are needed to elucidate the common regulatory pathways that may lead to MR irrespective of its cause.

Abstract Image

Abstract Image

Abstract Image

二尖瓣返流的遗传性:来自弗雷明汉心脏研究和瑞典人群的观察。
背景:家族聚集已被描述为二尖瓣脱垂引起的原发性二尖瓣反流(MR)。我们假设MR的遗传性存在于不同的MR亚型中,包括非原发性MR。方法和结果:研究参与者是FHS (Framingham心脏研究)第3代(第3代)和第2代队列参与者,以及1997年确定的所有1932年以后出生的瑞典成年兄弟姐妹,随访至2010年。磁共振被定义为FHS和瑞典国际疾病分类代码的彩色多普勒≥轻度反流。我们估计了2代/ 3代/瑞典兄弟姐妹的兄弟姐妹MR与MR的关系。我们还估计了539个FHS家系(7580个个体)MR的遗传力。在5132名有兄弟姐妹信息的FHS第二代/第三代参与者中,1062名患有MR。在有兄弟姐妹有MR的兄弟姐妹中,28%(500/1797)患有MR,而没有兄弟姐妹有MR的兄弟姐妹为17%(562/3335)(多变量调整优势比为1.20;95%置信区间[CI], 1.01-1.43;P = 0.04)。当我们结合FHS家系中亲本和兄弟姐妹的数据时,MR的遗传力估计为0.15 (95% CI, 0.07-0.23),排除二尖瓣脱出的MR的遗传力估计为0.12 (95% CI, 0.04-0.20),≥中度MR的遗传力估计为0.44 (95% CI, 0.15-0.73)(所有ppp结论:MR在社区中存在家族聚类,支持原发性和非原发性MR共同的遗传易感性,需要进一步的研究来阐明可能导致MR的共同调控途径,而不管其原因如何。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Circulation: Cardiovascular Genetics
Circulation: Cardiovascular Genetics CARDIAC & CARDIOVASCULAR SYSTEMS-GENETICS & HEREDITY
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: Circulation: Genomic and Precision Medicine considers all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信